Transforming growth factor-beta 1 stimulates angiotensinogen gene expression in kidney proximal tubular cells

Kidney International

Volumn 69, Issue 11, 2006, Pages 1977-1985

  Brezniceanu, M L ^a   Wei, C C ^a   Zhang, S L ^a   Hsieh, T J ^a   Guo, D F ^a   Hebert M J ^a   Ingelfinger, J R ^b   Filep, J G ^c   Chan, J S D ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Reactive oxygen species kidney; Renin angiotensin system; TGF 1

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANGIOTENSINOGEN; COMPLEMENTARY DNA; LOSARTAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PERINDOPRIL; PROTEIN P53; REACTIVE OXYGEN METABOLITE; RENIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION; KIDNEY DISEASE; KIDNEY PROXIMAL TUBULE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANGIOTENSINOGEN; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; KIDNEY TUBULES, PROXIMAL; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33745260907     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000396     Document Type: Article

References (55)

1. Border WA, Okuda S, Languino LR et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 1990; 346: 371-374.
2. Yamamoto T, Nakamura T, Noble NA et al. Expression of transforming growth factor-β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 1993; 90: 1814-1818.
3. Sharma K, Eltayeb BO, McGowan TA et al. Captopril-induced reduction of serum levels of transforming growth factor-beta 1 correlates with long-term renoprotection in insulin-dependent diabetic patients. Am J Kidney Dis 1999; 34: 818-823.
4. Kopp JB, Factor VM, Mozes M et al. Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab Invest 1996; 74: 991-1003.
5. McGowan TA, Zhu Y, Sharma K. Transforming growth factor-beta: a clinical target for the treatment of diabetic nephropathy. Curr Diab Rep 2004; 4: 447-454.
6. Wenner CE, Yan S. Biphasic role of TGF-beta1 in signal transduction and crosstalk. J Cell Physiol 2003; 196: 42-50.
7. Remy I, Montmarquette A, Michnick SW. PKB/Akt modulates TGF-beta signalling through a direct interaction with Smad3. Nat Cell Biol 2004; 6: 358-365.
8. Ma LJ, Yang H, Gaspert A et al. Transforming growth factor-beta-dependent and independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice. Am J Pathol 2003; 163: 1261-1273.
9. Ziyadeh FN, Hoffman BB, Han DC et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 2000; 97: 8015-8020.
10. Border WA, Okuda S, Languino LR, Ruoslahti E. Transforming growth factor-β regulates production of proteoglycans in mesangial cells. Kidney Int 1990; 37: 689-695.
11. Nakamura T, Miller D, Ruoslahtj E, Border WA. Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β. Kidney Int 1992; 41: 1213-1221.
12. Williams AO, Knapton AD, Geiser A et al. The liver in transforming growth factor-beta1 (TGF-β1) null mutant mice. Ultrastruct Pathol 1996; 20: 477-190.
13. Wogensen L, Nielsen CB, Hjorth P et al. Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice. Diabetes 1999; 48: 182-192.
14. Conery AR, Cao Y, Thompson EA et al. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta-induced apoptosis. Nat Cell Biol 2004; 6: 366-372.
15. Cordenonsi M, Dupont S, Maretto S et al. Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads. Cell 2003; 113: 301-314.
16. Franklin CC, Rosenfeld-Franklin ME, White C et al. TGFbeta1-induced suppression of glutathione antioxidant defenses in hepatocytes: caspase-dependent post-translational and caspase-independent transcriptional regulatory mechanisms. FASEB J 2003; 17: 1535-1537.
17. Perlman R, Schiemann WP, Brooks MW et al. TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat Cell Biol 2001; 3: 708-714.
18. Fan JM, Ng YY, Hill PA et al. Role of proteoglycans and cytoskeleton in the effects of TGF-β regulates tubular epithelial myofibroblast transdifferentiation in vitro. Kidney Int 1999; 56: 1455-1467.
19. Karihaloo A, Nickel C, Cantley LG. Signals: which build a tubule. Nephron Exp Nephrol 2005; 100: e40-e45.
20. 2-generating NADH oxidase in human lung fibroblasts by transforming growth factor beta-1. J Biol Chem 1995; 270: 30334-30338.
21. Albright CD, Salgeanik RI, Craciuneseu CN et al. Mitochondrial and microsomal derived reacting oxygen species mediate apoptosis induced by transforming growth factor-beta 1 in immortalized rat hepatocyte. J Cell Biochem 2003; 89: 254-261.
22. Jiang Z, Seo JY, Ha H et al. Reactive oxygen species mediates TGF-beta 1-induced plasminogen activator inhibitor-1 upregulation in mesangial cells. Biochem Biophys Res Commun 2003; 309: 961-966.
23. Rhyu DY, Yang Y, HA H, Lee GT et al. Role of reactive oxygen species in TGF-beta 1 induced mitogen-activated protein kinase activation and epithelial mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 2005; 16: 667-675.
24. Zhang S-L, Filep JG, Hohman TC et al. Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. Kidney Int 1999; 55: 454-464.
25. Zhang SL, To C, Chen X et al. Essential role(s) of the intrarenal renin-angiotensin system in transforming growth factor-beta1 gene expression and induction of hypertrophy of rat kidney proximal tubular cells in high glucose. J Am Soc Nephrol 2002; 13: 302-312.
26. Zhang SL, To C, Chen X et al. Effect of renin-angiotensin system blockade on the expression of the angiotensinogen gene and induction of hypertrophy in rat kidney proximal tubular cells. Exp Nephrol 2001; 9: 109-117.
27. Hsieh T-J, Zhang S-L, Filep JG et al. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology 2002; 143: 2975-2986.
28. Hsieh TJ, Fustier P, Zhang SL et al. High glucose stimulates angiotensinogen gene expression and cell hypertrophy via activation of the hexosamine biosynthesis pathway in rat kidney proximal tubular cells. Endocrinology 2003; 144: 4338-4349.
29. Chan JSD, Ming M, Nie ZR. Hormonal regulation of expression of the angiotensinogen gene in cultured opossum kidney proximal tubular cells. J Am Soc Nephrol 1992; 2: 1516-1522.
30. Miyajima A, Chen J, Lawrence C et al. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 2000; 58: 2301-2313.
31. Kolek O, Gajkowska B, Godlewski MM, Motyl T. Molecular mechanism of TGF-beta1-induced apoptosis in HC11 mouse mammary epithelial cells (MEC). Cell Mol Biol 2001; 47: 197-208.
32. Sola S, Ma X, Castro RE et al. Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor beta1-induced apoptosis of rat hepatocytes. J Biol Chem 2003; 278: 48831-48838.
33. Leri A, Claudio PP, Li Q et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest 1998; 101: 1326-1342.
34. Fiordaliso F, Leri A, Cesselli D et al. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. Diabetes 2001; 50: 2363-2375.
35. Wolf G, Schroeder R, Zahner G et al. High glucose-induced hypertrophy of mesangial cells requires p27 Kip1, an inhibitor of cyclin-dependent kinases. Am J Pathol 2001; 158: 1091-1100.
36. Monkawa T, Hiromura K, Wolf G, Shankland SJ. The hypertrophic effect of transforming growth factor-beta is reduced in the absence of cyclin-dependent kinase-inhibitors p21 and p27. J Am Soc Nephrol 2002; 13: 1172-1178.
37. Wolf G, Wenzel UO. Angiotensin II and cell cycle regulation. Hypertension 2004; 43: 693-698.
38. Awazu M, Omori S, Ishikura K et al. The lack of cyclin kinase inhibitor p27Kip1 ameliorates progression of diabetic nephropathy. J Am Soc Nephrol 2003; 14: 699-708.
39. Ha H, Park J, Kim YS, Endou H. Oxidative stress and chronic allograft nephropathy. Yonsei Med J 2004; 45: 1049-1052.
40. kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals. Kidney Int 1988; 54: 1923-1933.
41. Benzie IFF, Tomlinson B. Antioxidant power of angiotensin-converting enzyme inhibitors in vitro. Br J Clin Pharmacol 1998; 45: 168-169.
42. Pierzchalski P, Reiss K, Cheng W et al. p53 Induces myocyte apoptosis via activation of the renin-angiotensin system. Exp Cell Res 1997; 234: 57-65.
43. Lee HB, Yu M-R, Yang Y et al. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 2003; 14: S241-S245.
44. Kim SJ, Hwang SG, Shin DY et al. p38 kinase regulates nitric oxide-induced apoptosis of articular chondrocytes by accumulating p53 via NFkappa B-dependent transcription and stabilization by serine 15 phosphorylation. J Biol Chem 2002; 277: 33501-33508.
45. Wang L, Lei C, Zhang S-L et al. Synergistic effect of dexamethasone and isoproterenol on the expression of angiotensinogen in immortalized rat proximal tubular cells. Kidney Int 1998; 53: 287-295.
46. Qian SW, Kondaiah P, Roberts AB, Sporn MB. cDNA cloning by PCR of rat transforming growth factor-beta1. Nucleic Acids Res 1990; 18: 3059.
47. Hulla JE, Schneider RP. Structure of the rat p53 tumor suppressor gene. Nucleic Acids Res 1993; 21: 713-717.
48. Ingelfinger JR, Jung F, Diamond D et al. Rat proximal tubular cell line transformed with origin-defective SV40 DNA: autocrine Ang II feedback. Am J Physiol 1999; 276: F218-F227.
49. Kanalas JJ, Hopfer U. Effect of TGF-beta 1 and TNF-alpha on the plasminogen system of rat proximal tubular epithelial cells. J Am Soc Nephrol 1997; 8: 184-192.
50. Vinay P, Gougoux A, Lemieux G. Isolation of a pure suspension of rat proximal tubules. Am J Physiol 1981; 241: F403-F411.
51. Zhang S-L, Chen X, Hsieh T-J et al. Hyperglycemia induces insulin resistance on angiotensinogen gene expression in diabetic rat kidney proximal tubular cells. J Endocrinol 2002; 172: 333-344.
52. Ohkubo H, Kageyama R, Ujihara M et al. Cloning and sequence analysis of cDNA for rat angiotensinogen. Proc Natl Acad Sci USA 1983; 80: 2196-3000.
53. Clouston WM, Evans BA, Haralambidis J, Richards RI. Molecular cloning of the mouse angiotensinogen gene. Genomics 1988; 2: 240-248.
54. Zeheb R, Gelehrter TD. Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1. Gene 1988; 73: 459-468.
55. Nudel U, Zakut R, Shani M et al. The nucleotide sequence of the rat cytoplasmic β-actin gene. Nucleic Acids Res 1983; 11: 1759-1771.